Peter E. Fecci, MD, PhD, discusses therapeutic advances and challenges in the management of glioblastoma, and the trajectory of immunotherapy development.
CU Anschutz
Anschutz Cancer Pavilion
1665 North Aurora Court
2004
Aurora, CO 80045
Dr Fecci on Immunotherapy Research Innovations in Glioblastoma
minute read
by OncLive | July 15, 2026
